Gilead Sciences (GILD)
5 Buy-Rated Biotech Stocks to Bolster Your Portfolio
5 Buy-Rated Biotech Stocks to Bolster Your Portfolio
Biotech stocks have been picking up steam lately and several positive catalysts could keep the wind at the industry's back. Here are five names analys…
November 8, 2021
9 Big Pharmaceutical Stocks Sporting Stellar Yields
9 Big Pharmaceutical Stocks Sporting Stellar Yields
Large-cap pharmaceutical stocks offer investors stable, substantial dividends, regardless of market conditions. Here are nine that stand out.
October 5, 2021
5 High-Yield Dividend Stocks for Healthy Income
5 High-Yield Dividend Stocks for Healthy Income
The healthcare sector is chock-full of safe, sturdy income plays. But these five top-rated high-yield dividend stocks really stand out in the crowd.
August 3, 2021
Stock Market Today 10/22/20: Stimulus' Siren Song Pulls the Bulls Along
Stock Market Today 10/22/20: Stimulus' Siren Song Pulls the Bulls Along
Thursday's gains were driven by more positive language on stimulus negotiations, but an uncertain timeline kept those advances modest.
October 22, 2020
Stock Market Today 9/14/20: Big Deal! Stocks Solidly in the Black on 'M&A Monday'
Stock Market Today 9/14/20: Big Deal! Stocks Solidly in the Black on 'M&A Monday'
Big dealmaking from Nvidia (NVDA) and Gilead Sciences (GILD), as well as renewed COVID vaccine hopes, sent a jolt into stocks Monday.
September 14, 2020
Subscribe to Kiplinger's Personal Finance
Be a smarter, better informed investor.
Closing Bell 7/13/20: This Is Your Market on (Coronavirus) Drugs
Closing Bell 7/13/20: This Is Your Market on (Coronavirus) Drugs
A rapid rally to start the week, sparked by encouraging vaccine news from Pfizer and BioNTech, collapsed in the afternoon.
July 13, 2020
Closing Bell 7/10/20: Gilead Gives Stocks a Booster Shot
Closing Bell 7/10/20: Gilead Gives Stocks a Booster Shot
Stocks rallied out of negative territory Friday after Gilead announced that remdesivir helped reduce COVID-19 mortality risk in a clinical trial.
July 10, 2020
Gilead Sciences' (GILD) Remdesivir Sparks Market Hope With Trial Success
Gilead Sciences' (GILD) Remdesivir Sparks Market Hope With Trial Success
Gilead's COVID-19 treatment shows efficacy in Phase 3 trial, NIAID study
April 29, 2020
How to Survive the Economic Fallout from COVID-19
How to Survive the Economic Fallout from COVID-19
The bull market and economic expansion are over. Here's what to do now.
March 26, 2020
10 Value Stocks to Buy for 2018 and Beyond
10 Value Stocks to Buy for 2018 and Beyond
The stock market was unkind to Warren Buffett disciples in 2017.
January 12, 2018
5 Undervalued Stocks With Free Cash Flow to Burn
5 Undervalued Stocks With Free Cash Flow to Burn
Look beyond the P/E. These five firms are inexpensive based on free cash flow.
September 22, 2017
Why I'm Hanging On to a Loser
Why I'm Hanging On to a Loser
Gilead is way down from when I bought it, but it is flush with cash and has dozens of promising medications in its pipeline.
August 24, 2017
Can This Fallen Biotech Be Revived?
Can This Fallen Biotech Be Revived?
I've been sorely tempted to sell my Gilead shares. But now that they're cheaper, maybe I should buy more.
April 12, 2017
This Stumbling Biotech Stock Still Has a Lot of Promise
This Stumbling Biotech Stock Still Has a Lot of Promise
Gilead Sciences' robust product pipeline should turn things around.
January 3, 2017
3 Bargain Stocks to Beat the Market
3 Bargain Stocks to Beat the Market
The Value Line Investment Survey sees a strong year ahead for these picks.
June 2, 2015
Promising Bargains in Biotech Stocks
Promising Bargains in Biotech Stocks
What I like about BioDelivery Sciences is not so much that there are many ways to win as that there are almost no ways to lose.
October 6, 2014